SPDL1 and acute respiratory distress syndrome: In this study, we demonstrated that soluble programmed death ligand-1 (sPD-L1) mRNA delivered using DOTAP-added lipid nanoparticles (LNPs) can be expressed by lung tissue specifically, achieving in situ immune suppression in ARDS lung tissue.